Left Atrial Structural and Functional Response in Kidney Transplant Recipients Treated With Mesenchymal Stromal Cell Therapy and Early Tacrolimus Withdrawal

被引:8
|
作者
Meucci, Maria Chiara [1 ,4 ]
Reinders, Marlies E. J. [2 ,5 ]
Groeneweg, Koen E. [2 ]
Bezstarosti, Suzanne [2 ,3 ]
Marsan, Nina Ajmone [1 ]
Bax, Jeroen J. [1 ,6 ]
De Fijter, Johan W. [2 ]
Delgado, Victoria [1 ,7 ]
机构
[1] Leiden Univ, Med Ctr, Dept Cardiol, Albinusdreef 2, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Immunol, Leiden, Netherlands
[4] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc Med, Rome, Italy
[5] Erasmus MC, Erasmus Univ Med Ctr, Transplant Inst, Dept Internal Med, Rotterdam, Netherlands
[6] Univ Turku, Turku Univ Hosp, Heart Ctr, Turku, Finland
[7] Hosp Badalona Germans Trias & Pujol, Fundacio Inst Invest Ciencies Salut Germans Trias, Badalona, Spain
关键词
Left atrium; Atrial function; Kidney transplantation; Mesenchymal stem cells; Immunosuppression; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; DISEASE; ECHOCARDIOGRAPHY; RECOMMENDATIONS; OUTCOMES; UPDATE; VOLUME;
D O I
10.1016/j.echo.2022.10.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Autologous bone marrow-derived mesenchymal stromal cell (MSC) therapy and withdrawal of calcineurin inhibitors (CNIs) has been shown to improve systemic blood pressure control and left ventricular hypertrophy regression in kidney transplant recipients. In the current subanalysis, we aimed to evaluate the impact of this novel immunosuppressive regimen on the longitudinal changes of left atrial (LA) structure and function after kidney transplantation.Methods: Kidney transplant recipients randomized to MSC therapy-infused at weeks 6 and 7 after transplan-tation, with complete discontinuation at week 8 of tacrolimus (MSC group)-or standard tacrolimus dose (con-trol group) were evaluated with transthoracic echocardiography at weeks 4 and 24 after kidney transplantation. The changes in echocardiographic parameters were compared between the randomization arms using an analysis of covariance model adjusted for baseline variable.Results: Fifty-four participants (MSC therapy = 27; tacrolimus therapy = 27) were included. There was no signif-icant interaction between the allocated treatment and the changes of indexed maximal LA volume (LAVImax) over the study period. Conversely, between 4 and 24 weeks post-transplantation, an increase in indexed minimal LA volume (LAVImin) was observed in control subjects, while it remained unchanged in the MSC group, leading to a significant difference between groups (P = .021). Additionally, patients treated with MSC therapy showed a benefit in LA function, assessed by a significant interaction between changes in LA emptying fraction and LA reservoir strain and the randomization arm (P = .012 and P = .027, respectively).Conclusions: The combination of MSC therapy and CNIs withdrawal prevents progressive LA dilation and dysfunction in the first 6 months after kidney transplantation. LAVImin and LA reservoir strain may be more sen-sitive markers of LA reverse remodeling, compared with LAVImax. (J Am Soc Echocardiogr 2023;36:172-9.)
引用
收藏
页码:172 / 179
页数:8
相关论文
共 50 条
  • [31] PREVALENCE OF HYPERTENSION USING AMBULATORY BLOOD PRESSURE MONITORING IN PAEDIATRIC KIDNEY TRANSPLANT RECIPIENTS TREATED WITH EARLY STEROID WITHDRAWAL IMMUNOSUPPRESSIVE REGIMES.
    Dowsett, Thomas
    Shenoy, Mohan
    PEDIATRIC NEPHROLOGY, 2022, 37 (11) : 2881 - 2881
  • [32] Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients
    Marlies EJ Reinders
    Jonna R Bank
    Geertje J Dreyer
    Helene Roelofs
    Sebastian Heidt
    Dave L Roelen
    Volkert AL Huurman
    Jan Lindeman
    Cees van Kooten
    Frans HJ Claas
    Wim E Fibbe
    Ton J Rabelink
    Johan W de Fijter
    Journal of Translational Medicine, 12
  • [33] Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients
    Reinders, Marlies E. J.
    Bank, Jonna R.
    Dreyer, Geertje J.
    Roelofs, Helene
    Heidt, Sebastian
    Roelen, Dave L.
    Huurman, Volkert A. L.
    Lindeman, Jan
    van Kooten, Cees
    Claas, Frans H. J.
    Fibbe, Wim E.
    Rabelink, Ton J.
    de Fijter, Johan W.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [34] EFFECT OF EARLY CONVERSION TO EVEROLIMUS VERSUS CONTINUED CNI THERAPY ON LEFT VENTRICULAR HYPERTROPHY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
    Van der Giet, Markus
    Holdaas, Hallvard
    De Fijter, Johan W.
    Speziale, Antonio
    Escrig, Cesar
    Junge, Guido
    Wang, Zailong
    Cruzado, Josep M.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 488 - 488
  • [35] COVID-19 Vaccination Response in Tacrolimus Treated Kidney Transplant Recipients with and without Mycophenolate Mofetil: Follow-Up of a Randomized Controlled Trial
    Al Fatly, Z.
    Betjes, M. G.
    Messchendorp, A. L.
    Sanders, J. S.
    Reinders, M. E.
    Kho, M. M.
    de Weerd, A. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 597 - 597
  • [36] Comparative Effectiveness of Triple Immunosuppressive Therapy Versus Steroid Avoidance or Early Withdrawal Among Kidney Transplant Recipients Over Age 65.
    Harris, M.
    Irish, W.
    Pura, J.
    Barbas, A.
    Englum, B.
    Sanoff, S.
    Ellis, M.
    Vikraman, D.
    Ravindra, K.
    Kuchibhatla, M.
    Sudan, D.
    Patel, U.
    TRANSPLANTATION, 2014, 98 : 144 - 145
  • [37] Comparative Effectiveness of Triple Immunosuppressive Therapy Versus Steroid Avoidance or Early Withdrawal Among Kidney Transplant Recipients Over Age 65.
    Harris, M.
    Irish, W.
    Pura, J.
    Barbas, A.
    Englum, B.
    Sanoff, S.
    Ellis, M.
    Vikraman, D.
    Ravindra, K.
    Kuchibhatla, M.
    Sudan, D.
    Patel, U.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 144 - 145
  • [38] Donor ABCB1 3435 C>T genetic polymorphisms influence early renal function in kidney transplant recipients treated with tacrolimus
    Yan, Lin
    Li, Yi
    Tang, Jiang-Tao
    An, Yun-Fei
    Wang, Lan-Lan
    Shi, Yun-Ying
    PHARMACOGENOMICS, 2016, 17 (03) : 249 - 257
  • [39] A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients (vol 8, pg 307, 2008)
    Vincenti, F.
    Schena, F. P.
    Paraskevas, S.
    Hauser, I. A.
    Walker, R. G.
    Grinyo, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (05) : 1080 - 1080
  • [40] CHANGES IN DONOR-SPECIFIC CELL-MEDIATED LYMPHOLYSIS (CML) RESPONSE ASSOCIATED WITH SUCCESS OF EARLY STEROID WITHDRAWAL IN DST-AZATHIOPRINE-TREATED RENAL-TRANSPLANT RECIPIENTS
    BURLINGHAM, WJ
    GRAILER, A
    SOLLINGER, HW
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 1818 - 1819